Martha Martin's family faces the daunting challenge of quarantine after her infant son was exposed to measles. With no vaccine available for his age, they navigate the stress of unpaid leave and child care amidst a rising outbreak.
A new monoclonal antibody called clesrovimab has been recommended for infants to prevent RSV, stirring debate among health experts and advocates. The FDA approved the treatment just weeks ago.
Merck's new drug ENFLONSIA has received FDA approval for preventing RSV in newborns and infants, promising significant reductions in hospitalizations and severe respiratory illness. This long-acting monoclonal antibody offers hope for parents facing RSV season challenges.
A new guideline from the US Preventive Services Task Force emphasizes the importance of syphilis screening for pregnant women as cases surge, with alarming implications for stillbirths and infant health.
Whooping cough cases have skyrocketed in the U.S., doubling from last year and leading to tragic deaths among young children. Experts warn that declining vaccination rates are a major factor. Learn more about the alarming rise in this preventable disease.
Whooping cough cases in the U.S. have surged to alarming levels, with 8,077 cases reported in 2025, compared to just 3,847 last year. Experts warn of rising deaths among infants and link the outbreak to declining vaccination rates.
